ADC Therapeutics SA Reports Third Quarter 2026 Net Product Revenue of $21.0 million and Cash of $189.2 million
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates
ADC Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Updates
ADC Therapeutics Q3 Adj. EPS $(0.06) Beats $(0.21) Estimate, Sales $21.716M Beat $18.692M Estimate
ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Data at ASH and Strategic Financial Restructuring - Slideshow
ADC Therapeutics SA Announces ZYNLONTA Clinical Trial Data and Financial Restructuring
ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Data at ASH and Strategic Financial Restructuring Transcript
ADC Therapeutics Reports Strong Lymphoma Responses, Plans Phase III Study
ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program
ADC Therapeutics to Present at November Investor Conferences
ADC Therapeutics Announces New Employee Inducement Grant
ADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026
ADC Therapeutics Announces ZYNLONTA® Updates in Japan
ADC Therapeutics Cuts Debt, Extends Runway Ahead of Key Drug Data, RBC Says
ADC Therapeutics: Shares Spike On Restructuring, But Safety Fears Undermine Bull Thesis
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics Announces $86.6M Pipe Financing For 12.9M Shares At $1.42/Share And Warrants To Purchase 48.1M Shares At $1.32/Warrant; Secures Loan And Royalty Amendments
ADC Therapeutics SA (ADCT) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference - Slideshow
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
ADC Therapeutics (ADCT) Price Target Increased by 43.18% to 2.68
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.